Vergoeding 2014-2018 voor ATC-subgroep C07AB : Selectieve beta-blokkers
- Raming voor de totale Zvw-populatie
| 2014 | 2015 | 2016 | 2017 | 2018 | |
|---|---|---|---|---|---|
| C07AB02 Metoprolol (Selokeen ®) | 13.054.600 | 13.084.800 | 12.069.900 | 12.069.400 | 12.600.600 |
| C07AB03 Atenolol | 1.071.600 | 1.100.600 | 1.054.000 | 1.036.900 | 1.002.100 |
| C07AB04 Acebutolol | 140.250 | 127.050 | 115.160 | 96.200 | 89.797 |
| C07AB07 Bisoprolol (Emcor ®) | 2.027.400 | 2.136.300 | 2.179.200 | 2.261.500 | 2.392.500 |
| C07AB08 Celiprolol (Dilanorm ®) | 371.250 | 350.690 | 360.730 | 355.740 | 314.850 |
| C07AB12 Nebivolol (Nebilet ®) | 1.015.600 | 1.061.700 | 1.129.500 | 1.055.500 | 1.138.400 |
| Totaal | 17.680.700 | 17.861.140 | 16.908.490 | 16.875.240 | 17.538.247 |